Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva collapse continues on Wall Street - Globes
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Building on Strong First Quarter, Teva Raises 2018 Outlook | Ctech
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva's $4 Billion Medicine Faces Patent Judgment Day in U.S. - Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Pharmaceuticals - Wikipedia
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva stock drops after conspiracy allegations on hiking drug prices
Teva's Working With Evercore to Review Debt Options - Bloomberg
Berkshire's 4th Quarter Buy Teva Appears Cheap And Troubled
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva, AbbVie may pay billions to settle opioid lawsuits
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva Faces Rocky Path to Recovery After Debt | Fortune
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
